Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 979993269
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2015.02.19, US 201562118208 P
2015.03.31, US 201562141120 P
2015.10.01, US 201562235823 P
EP-A1- 2 067 791 (B1)
GALIT ROTMAN ET AL: "Identification of novel immune checkpoints as targets for cancer immunotherapy", JOURNAL FOR IMMUNOTHERAPY OF CANCER, BIOMED CENTRAL LTD, LONDON, UK, vol. 1, no. Suppl 1, 7 November 2013 (2013-11-07), page P135, XP021167082, ISSN: 2051-1426, DOI: 10.1186/2051-1426-1-S1-P135 (B1)
Gene Id: "PVRIG antibody -middle region Rabbit Polyclonal Antibody Catalog # AI13083 Specification PVRIG antibody -middle region -Product Information Application WB Primary Accession Q6DKI7 Other Accession NM_024070, NP_076975 Reactivity Human Predicted Human Host Rabbit Clonality Polyclonal Calculated MW 34k", Physiol. Genomics, 1 January 2006 (2006-01-01), pages 201-218, XP055273924, Retrieved from the Internet: URL:http://www.funakoshi.co.jp/data/datash eet/ABG/AI13083.pdf (B1)
IBA Y ET AL: "CHANGES IN THE SPECIFICITY OF ANTIBODIES AGAINST STEROID ANTIGENS BY INTRODUCTION OF MUTATIONS INTO COMPLEMENTARITY-DETERMINING REGIONS OF THE VH DOMAIN", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 11, no. 5, 1 January 1998 (1998-01-01), pages 361-370, XP002953909, ISSN: 0269-2139, DOI: 10.1093/PROTEIN/11.5.361 (B1)
N. STANIETSKY ET AL: "The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 106, no. 42, 20 October 2009 (2009-10-20), pages 17858-17863, XP055215810, ISSN: 0027-8424, DOI: 10.1073/pnas.0903474106 (B1)
RUDIKOFF S ET AL: "Single amino acid substitution altering antigen-binding specificity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 79, 1 March 1982 (1982-03-01), pages 1979-1983, XP007901436, ISSN: 0027-8424, DOI: 10.1073/PNAS.79.6.1979 (B1)
ZHU YUWEN ET AL: "Identification of CD112R as a novel checkpoint for human T cells", JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIV. PRESS, NEW YORK, NY, USA, vol. 213, no. 2, 8 February 2016 (2016-02-08), pages 167-176, XP009190107, ISSN: 1540-9538 (B1)
WO-A1-2012/178128 (B1)
WO-A1-2017/021526 (B1)
WO-A1-2017/041004 (B1)
WO-A2-2004/058805 (B1)
XIN YU ET AL: "The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells", NATURE IMMUNOLOGY, vol. 10, no. 1, 1 January 2009 (2009-01-01), pages 48-57, XP055273979, GB ISSN: 1529-2908, DOI: 10.1038/ni.1674 (B1)
WINKLER K ET AL: "Changing the antigen binding specificity by single point mutations of an anti-p24 (HIV-1) antibody", THE JOURNAL OF IMMUNOLOGY, WILLIAMS & WILKINS CO, US, vol. 165, no. 8, 15 October 2000 (2000-10-15), pages 4505-4514, XP002579393, ISSN: 0022-1767 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3653221)
|
Utgående
EP Registreringsbrev (3210) (PTEP3653221)
|
Innkommende, AR512261050
Korrespondanse (Hovedbrev inn)
|
Utgående
EP formelle mangler
|
Innkommende, AR511128482
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 10. avg. år (EP) | 2025.02.21 | 4160 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2024.02.20 | 2850 | PAVIS PAYMENTS GMBH | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2023.02.17 | 2550 | PAVIS PAYMENTS GMBH | Betalt og godkjent |
12200477 expand_more expand_less | 2022.11.09 | 5500 | BRYN AARFLOT AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|
||||
32214144 expand_more expand_less | 2022.10.31 | 5500 | BRYN AARFLOT AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|
||||
32213519 expand_more expand_less | 5500 | BRYN AARFLOT AS | Anullert/ kreditert | |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|